ilumya - tildrakizumab - asmn injection, solution
(Tildrakizumab-Asmn)Sun Pharmaceutical Industries, Inc.
Usage: Ilumya treats adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
Interleukin-23 Antagonists [MoA] class drugs
17 results
imuldosa - ustekinumab - srlf injection
(Ustekinumab-Srlf)Golden State Medical Supply, Inc.imuldosa - ustekinumab - srlf injection
(Ustekinumab-Srlf)Accord Biopharma Inc.omvoh - mirikizumab - mrkz injection, solution
(Mirikizumab-Mrkz)Eli Lilly And CompanyUsage: Omvoh treats moderately to severely active ulcerative colitis and Crohn's disease in adults.otulfi - ustekinumab - aauz injection, solution
(Ustekinumab-Aauz)Fresenius Kabi Usa, Llcpyzchiva - ustekinumab - ttwe injection, solution
(Ustekinumab-Ttwe)Cordavis Limitedpyzchiva - ustekinumab - ttwe injection, solution
(Ustekinumab-Ttwe)Sandoz Incskyrizi - risankizumab - rzaa
(Risankizumab-Rzaa)Abbvie Inc.Usage: SKYRIZI treats moderate-to-severe plaque psoriasis, active psoriatic arthritis, moderately to severely active Crohn's disease, and moderately to severely active ulcerative colitis in adults.starjemza
(Ustekinumab-Hmny)Hikma Pharmaceuticals Usa Inc.stelara - ustekinumab injection, solution
(Ustekinumab)Janssen Biotech, Inc.Usage: STELARA treats moderate-to-severe plaque psoriasis and active psoriatic arthritis in adults and pediatric patients 6 years and older. It also treats moderately to severely active Crohn's disease and ulcerative colitis in adults.